Muscular Dystrophy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For patients with a neuromuscular condition:
- People with a confirmed genetic diagnosis of Duchenne muscular dystrophy (DMD), facioscapulohumeral muscular dystrophy (FSHD), myotonic dystrophy type 1 (DM1), Charcot-Marie-Tooth disease (CMT), or FKRP gene mutations, or a confirmed diagnosis of centronuclear myopathy (CNM) based on a muscle biopsy.
- Patients with FSHD, DM1, CMT, or CNM who are still able to walk, or are at a stage where walking ability is changing.
- Patients with DM1 or CMT who show signs affecting both sensation and movement during a physical examination.
- Patients with DMD or CNM who are under 20 years old, or patients with FSHD, CMT, or DM1 who are between 5 and 80 years old.
- Patients with FKRP gene mutations who are older than 2 years.
- DMD patients who cannot walk but are able to sit in a regular or wheelchair for at least one hour.
- DMD patients who have been taking corticosteroid medication for at least 6 months, or who begin corticosteroid treatment at the start of the trial (except children under 4 years old).
- Patients (or their parents or legal guardians, if the patient is a minor) who have signed the consent form agreeing to take part.
For healthy control participants:
- Boys and girls who are able to walk and are under 20 years old.
- Participants (or their parents or legal guardians, if the participant is a minor) who have signed the consent form agreeing to take part.
Who may not be able to join:
For patients with a neuromuscular condition:
- Patients with severe cognitive difficulties that would make it hard to understand or follow the exercises involved in the trial.
- Patients who have had surgery or a significant injury to their arms or legs within the past 6 months (applies to patients who can walk).
- Patients who have had another ongoing or recent neurological, hormonal, infectious, allergic, or inflammatory condition in the 3 weeks before joining the trial.
- Patients who are currently taking part in another clinical trial that involves a treatment or intervention.
- DMD patients who are at a transitional stage of walking ability but are not currently taking corticosteroids.
For healthy control participants:
- People who have had surgery or a significant injury to their arms or legs within the past 6 months.
- Athletes who compete at a national level.
- People who have had a muscle, neurological, infectious, or inflammatory condition in the 3 weeks before joining the trial.
- People who have a bone, joint, or neurological condition that affects the way they walk.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 043215695
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Stride velocity; Stride length; Stairs number; Stairs speed; Stairs height
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.